Honolulu – Pharmaceutical companies have agreed to pay $ 700 million to the Hawaii to settle the case on the effectiveness and protection of the blood plavix, the State Attorney General Office on Friday.
Last year, a court verdict was ordered to pay $ 916 million to three US-based supporters of the French Pharmaceutical Company and French Pharmaceutical Company Sanophi.
However, before deciding the appeal, a small settlement reached, the Attorney General Office said.
In a joint statement, agencies say “they are pleased to resolve this case and their companies are pleased to continue their focus on inventing, developing and supplying innovative drugs.”
The statement also said, “Plavix has assisted millions of people suffering from cardiovascular disease around the world for almost 3 years and it is about to be approved as the first row therapy through the topic of the world,” the statement added.
James Ashford, a judge of the first circuit court, discovered that about 5% of patients, especially non-Cacacians, could have a “reduced response” of plavix but companies could not update their labels, Attorney General Ann Lopez said last year.
No company acknowledged wrongdoing.
Governor Josh Green called it a “landmark settlement” and a “main victory” for the kingdom.
The Attorney General’s Office said the settlement equally divided $ 700 million between Bristol Myers Squibs and Sanophi, will be paid by the wire transfer by June 9, the Attorney General’s Office said.
Leave a Reply